Successful induction of antiphospholipid syndrome (APS) in two different non-autoimmune prone mouse strains, BALB/c and C57BL/6, was achieved by tetanus toxoid (TTd) hyperimmunization using different adjuvants (glycerol or aluminium hydroxide), and different adjuvant pretreatments (glycerol or Complete Freund’s Adjuvant (CFA)). APS had different manifestations of reproductive pathology in BALB/c and C57BL/6 mice: fetal resorption (as a consequence of extreme T-cell activation obtained in the course of pretreatment), and lowering of fecundity (as a consequence of polyclonal B-cell stimulation), respectively. In BALB/c mice fetal resorption coincided with glycerol and CFA pretreatments, while in C57BL/6 mice lowering of fecundity was most obvious in CFA-pretreated mice immunized with TTd in aluminium hydroxide. Both molecular mimicry and polyclonal B-cell activation occur in APS induction, with molecular mimicry effects being dominant in BALB/c mice, and polyclonal cell activation being dominant in C57BL/6 mice. Confirmation of molecular mimicry effects, which in the condition of T-cell stimulation generated fetal resorptions in the BALB/c strain, was achieved by passive infusion of monoclonal antibody (MoAb) T-26 specific for TTd and anti-β2-glycoprotein I obtained after TTd hyperimunization. High polyclonal B-cell activation in C57BL/6 mice prevented fetal resorption but induced fecundity lowering, as was the case in passive administration of MoAb T-26 in this mouse strain. Passive infusion of anti-idiotypic MoAb Y7 into C57BL/6 mice induced fetal resorptions and confirmed the above suggestion on the protective role of polyclonal B-cell stimulation in fetal resorptions.
Radway-BrightELInancMIsenbergDA. Animal models of the antiphospholipid syndrome. Rheumatology1999; 38: 591–601.
2.
AhmadiKWilsonCTiwanaH. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Rheumatology1998; 37: 1330–1333.
3.
BogdanosDPMieli-VerganiGVerganiD. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter?Clin Infect Dis2005; 40: 508–510.
4.
ChenLKChouYCTsaiST. Hepatitis C virus infection related Type 1 diabetes mellitus. Diabet Med2005; 22: 340–343.
5.
TiwanaHWilsonCAlvarezA. Crossreactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun1999; 67: 2769–2775.
6.
KhamaisiMShoenfeldYOrbachH. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol2004; 22: 767–770.
7.
MariA. Is there a causative role of tetanus toxoid vaccination in the development of allergy-like symptoms and the increasing prevalence of atopic diseases?Med Hypotheses2004; 63: 875–886.
8.
SelmiCBattezzatiPMGershwinME. Vaccines in 21st century: the genetic response and the innocent bystander. Autoimmun Rev2005; 4: 79–81.
9.
ToplakNAvcinT. Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans. Lupus2009; 18: 1186–1191.
10.
ShoenfeldY. Infections, vaccines and autoimmunity. Lupus2009; 18: 1127–1128.
11.
BlankMKrauseIFridkinM. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for infectious etiology of antiphospholipid syndrome. J Clin Invest2002; 109: 797–804.
12.
BlankMEisensteinMAschersonRACerveraRSchoenfeldY. The infectious origin of the antiphospholipid syndrome. In: SchoenfeldYRoseN (eds). Infection and AutoimmunityAmsterdam: Elsevier; 2004. 473–490.
13.
MeroniPL. Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. J Autoimmun2008; 30: 99–103.
14.
BilliauAMatthysP. Modes of action of Freud’s adjuvants in experimental models of autoimmune diseases. J Leuk Biol2001; 70: 849–860.
15.
StillsHFJr. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J2005; 46: 280–293.
16.
BartonGMMedzhitovR. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol2002; 14: 380–383.
17.
PulendranB. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev2004; 199: 227–250.
18.
NeteaMGKullbergBJde JongD. NOD2 mediates induction of the antiinflammatory signals induced by TLR2-ligands: implications for Crohn’s disease. Eur J Immunol2004; 34: 2052–2059.
19.
DuanBMorelL. Role of B-1a cells in autoimmunity. Autoimmun Rev2006; 5: 403–408.
20.
GhummanBBertramEMWattsTH. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo. J Immunol1998; 161: 3262–3270.
21.
BrewerJM. (How) do aluminum adjuvants work?Immunol Lett2006; 102: 10–15.
22.
LindbladEB. Freund’s adjuvants. In: O’HaganDT (eds). Methods in molecular medicine: vaccine adjuvants—preparation methods and research protocolsTotowa NJ: Humana Press; 2000. 49–63.
23.
KrieglsteinKGHenschenAHWellerU. Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. Eur J Biochem1991; 202: 41–51.
24.
European Bioinformatics Institute – European Molecular Biology Laboratory [Internet], Cambridgeshire, UK, [cited 2008 June 2]. Available from http://www.ebi.ac.uk/t-coffee/.
ShibuyaKRobinsonDZoninF. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol1998; 160: 1708–1716.
27.
ZhangFLiangZMatsukiN. A murine locus on chromosome 18 controls NKT cell homeostasis and Th cell differentiation. J Immunol2003; 171: 4613–4620.
HainesBBAngelesCVParmeleeAPMcLeanPABrodeurPH. Germline diversity of the expressed BALB/c VhJ558 gene family. Mol Immunol2001; 38: 9–18.
30.
YancopoulosDGMalynnABAltFW. Developmentally regulated and strain-specific expression of murine Vh gene families. J Exp Med1988; 168: 417–435.
31.
SeidlKJWilshireJAMackenzieJDKantorABHerzenbergLAHerzenbergLA. Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc Natl Acad Sci U S A1999; 96: 2262–2267.
32.
PellegriniAGuiñazúNAokiMP. Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. Int Immunol2007; 19: 1395–1402.
33.
WonW-JKearneyJF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol2002; 168: 5605–5611.
34.
LampropoulouVHoehligKRochT. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol2008; 180: 4763–4773.
35.
PellegriniACarrera-SilvaEAArocenaA. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity. Med Microbiol Immunol2011. (in press).
36.
ShoenfeldYAron-MaorA. Vaccination and autoimmunity – ‘vaccinosis’: a dangerous liaison?J Autoimmun2000; 14: 1–10.
37.
StojanovićMZivkovićIInić-KanadaA. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Microbiol Immunol2009; 53: 89–100.
38.
ZivkovicIStojanovicMPetrusicV. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice. Am J Reprod Immunol2011; 65: 492–502.
39.
ŽivkovićIPetrušićVStojanovićM. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant. Innate Immun. (in press).
40.
ZivkovicIPStojanovicMMPetrusicVZ. Network connectivity is shown to change in C57BL/6 mice during a continuing immune response subsequent to tetanus toxoid hyperimmunization. Biol Res2010; 43: 393–402.
41.
RadulovicMCiricBJurisicA. Expression of Y7 idiotope on IgM molecules from cord sera. In: LukicMMostarica-StojkovicMCuperlovicKColicM (eds). Immune regulation in health and diseaseLondon: Academic Press; 1997. 205–211.
42.
IvanovicVPopovicLKovacinaK. Detection of cross-reacting idiotypes in sera of lymphoma patients by inverse monoclonal radioimmunoassay. Acta Haematol1990; 84: 64–67.
43.
DimitrijevicLARadulovicMICiricBP. Human monoclonal IgM DJ binds to ssDNA and human commensal bacteria. Hum Antibodies1999; 9: 37–45.
44.
DimitrijevicLAStojanovicMCiricB. Expression of Y7 cross-reactive idiotope on human IgM molecules. Immunol Invest2004; 33: 1–14.
45.
DimitrijevicLRadulovicMCiricB. Immunochemical characterization of a murine monoclonal anti-idiotypic antibody. J Immunoassay1992; 13: 181–196.
46.
GiannakopoulosBPassamFRahgozarSKrilisSA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood2007; 109: 422–430.
RaschiETestoniCBosisioD. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood2003; 101: 3495–3500.
49.
Inic-KanadaAStojanovicMZivkovicI. Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecular mimicry. Am J Reprod Immunol2009; 61: 39–51.
